Page last updated: 2024-11-06

prednisolone and Cancer of Nose

prednisolone has been researched along with Cancer of Nose in 25 studies

Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.

Research Excerpts

Excerpt	Relevance	Reference
"Combination chemotherapy consisting of ifosfamide, methotrexate, etoposide, and prednisolone (IMEP) was active as first-line and second-line treatment for extranodal natural killer/T-cell lymphoma (NTCL)."	9.19	A phase II study of ifosfamide, methotrexate, etoposide, and prednisolone for previously untreated stage I/II extranodal natural killer/T-cell lymphoma, nasal type: a multicenter trial of the Korean Cancer Study Group. ( Bae, SH; Chung, J; Heo, DS; Hyun, MS; Jeon, YK; Kang, YK; Kim, BS; Kim, CW; Kim, DW; Kim, H; Kim, HJ; Kim, TM; Lee, JS; Song, HS; Yang, SH; Yuh, YJ, 2014)
"Combination chemotherapy consisting of ifosfamide, methotrexate, etoposide, and prednisolone (IMEP) was active as first-line and second-line treatment for extranodal natural killer/T-cell lymphoma (NTCL)."	5.19	A phase II study of ifosfamide, methotrexate, etoposide, and prednisolone for previously untreated stage I/II extranodal natural killer/T-cell lymphoma, nasal type: a multicenter trial of the Korean Cancer Study Group. ( Bae, SH; Chung, J; Heo, DS; Hyun, MS; Jeon, YK; Kang, YK; Kim, BS; Kim, CW; Kim, DW; Kim, H; Kim, HJ; Kim, TM; Lee, JS; Song, HS; Yang, SH; Yuh, YJ, 2014)
"A 3-month-old infant was administered high-dose systemic prednisolone for management of a hemangioma of the nasal sidewall."	3.71	An unusual complication of the treatment of a hemangioma. ( Balfour, I; Pokorny, JJ; Rinehart, G; Roth, F, 2002)
"Plasmablastic lymphoma is an aggressive variant of lymphomas recently distinct from diffuse large B cell lymphoma."	2.66	[Isolated plasmablastic lymphoma of nasal mucosa in an immunocompetent patient achieving complete remission after multimodal treatment: about an African patient and literature review]. ( Rais, H; Tazi, I; Tissir, R, 2020)

Research

Studies (25)

Timeframe	Studies, this research(%)	All Research%
pre-1990	4 (16.00)	18.7374
1990's	1 (4.00)	18.2507
2000's	11 (44.00)	29.6817
2010's	8 (32.00)	24.3611
2020's	1 (4.00)	2.80

Authors

Authors	Studies
Tissir, R	1
Rais, H	1
Tazi, I	1
Ando, Y	1
Maeshima, AM	1
Fukuhara, S	1
Makita, S	1
Munakata, W	1
Suzuki, T	1
Maruyama, D	1
Taniguchi, H	1
Izutsu, K	1
Bashyam, A	1
Nagala, S	1
Tahir, F	1
Mirza, S	1
Bouayad, N	1
Oubelkacem, N	1
Bono, W	1
Masbah, O	1
Bouhafa, T	1
Elmazghi, A	1
Khalid, H	1
Bostan, E	1
Akdogan, N	1
Saglam Ayhan, A	1
Ersoy Evans, S	1
Kim, TM	1
Kim, DW	1
Kang, YK	1
Chung, J	1
Song, HS	1
Kim, HJ	1
Kim, BS	1
Lee, JS	2
Kim, H	1
Yang, SH	1
Yuh, YJ	1
Bae, SH	1
Hyun, MS	1
Jeon, YK	1
Kim, CW	1
Heo, DS	1
Huang, L	1
Yuan, B	1
Wu, H	1
Chu, H	1
Liu, Y	1
Wu, S	1
Li, H	1
Lu, H	1
Chen, H	1
Léauté-Labrèze, C	1
Dumas de la Roque, E	1
Hubiche, T	1
Boralevi, F	1
Thambo, JB	1
Taïeb, A	1
Liu, X	1
Wang, B	1
Ma, X	1
Guo, Y	1
Ma, HH	1
Qian, LT	1
Pan, HF	1
Yang, L	1
Zhang, HY	1
Wang, ZH	1
Ma, J	1
Zhao, YF	1
Gao, J	1
Wu, AD	1
Williams, JV	1
Revington, PJ	1
ARDOUIN, AP	1
Obama, K	1
Tara, M	1
Niina, K	1
Kouzaki, H	1
Kitanishi, T	1
Kitano, H	1
Suzuki, M	1
Yong, W	2
Zheng, W	2
Zhu, J	1
Zhang, Y	2
Wei, Y	1
Wang, X	1
Lin, N	1
Xie, Y	1
Xu, B	1
Li, J	1
Tamai, Y	1
Imataki, O	1
Abe, Y	1
Hagiwara, S	1
Ito, I	1
Asakura, H	1
Harada, H	1
Kamata, M	1
Nishimura, T	1
Kawakami, K	1
Rhee, KH	1
Hong, SC	1
An, JM	1
Huh, J	1
Sook, RJ	1
Suh, C	1
Ginel, PJ	1
Molleda, JM	1
Novales, M	1
Martín, E	1
Margarito, JM	1
López, R	1
Naganobu, K	1
Ogawa, H	1
Uchida, K	1
Yamaguchi, R	1
Ohashi, F	1
Kubo, K	1
Aoki, M	1
Kuwamura, M	1
Ogawa, Y	1
Matsuyama, K	1
Pokorny, JJ	1
Roth, F	1
Balfour, I	1
Rinehart, G	1
Sanda, T	1
Lida, S	1
Ito, M	1
Tsuboi, K	1
Miura, K	1
Harada, S	1
Komatsu, H	1
Wakita, A	1
Inagaki, H	1
Ueda, R	1
Pace-Balzan, A	1
Timms, MS	1
Ghosh, ML	1
Sayeed, A	1
Vishwakarma, SK	1
Bhatia, ML	1

Clinical Trials (10)

Trial Overview

Trial	Phase	Enrollment	Study Type	Start Date	Status
Propanolol Effect on Red Cell Adhesion in Non-Asthmatic Children With Sickle Cell Disease: A Dose Finding Study[NCT02012777]	Phase 1	9 participants (Actual)	Interventional	2010-06-30	Terminated (stopped due to Inability to recruit patients into the study.)
A Randomised, Controlled, Multidose, Multicentre, Adaptive Phase II/III Study in Infants With Proliferating Infantile Hemangiomas (IHs) Requiring Systemic Therapy to Compare 4 Regimens of Propranolol (1 or 3 mg/kg/Day for 3 or 6 Months) to Placebo (Double[NCT01056341]	Phase 2/Phase 3	512 participants (Actual)	Interventional	2010-01-31	Completed
Propranolol vs Prednisolone for Infant Hemangiomas-A Clinical and Molecular Study[NCT00967226]	Phase 2	19 participants (Actual)	Interventional	2009-07-31	Terminated (stopped due to Serious adverse events with prednisolone, primarily temporary growth retardation, <5th percentile.)
Melablock: A Multicentre Randomized, Double---blinded and Placebo---controlled Clinical Trial on the Efficacy and Safety of Once Daily Propranolol 80 mg Retard for the Prevention of Cutaneous Malignant Melanoma Recurrence[NCT02962947]	Phase 2/Phase 3	546 participants (Anticipated)	Interventional	2017-06-30	Not yet recruiting
"'' Efficacy of Propranolol in the Treatment of Infantile Hemangioma"[NCT04684667]	Phase 2	100 participants (Anticipated)	Interventional	2021-01-01	Not yet recruiting
Phase 2 Study of Sildenafil for the Treatment of Lymphatic Malformations[NCT02335242]	Phase 2	22 participants (Actual)	Interventional	2015-05-23	Completed
A Comparative Study of the Use of Beta Blocker and Oral Corticosteroid in the Treatment of Proliferative and Involuting Cutaneous Infantile Hemangioma[NCT01072045]	Phase 2	50 participants (Actual)	Interventional	2010-01-31	Completed
A Modular Open Label, Signal Seeking, Phase II Trial of Targeted Therapies for Patients With Slow-Flow or Fast-Flow Vascular Malformations (TARGET-VM)[NCT05983159]	Phase 2	30 participants (Anticipated)	Interventional	2023-09-30	Not yet recruiting
Double Blind, Randomised, Placebo-controlled Study of Propranolol in Infantile Capillary Hemangiomas[NCT00744185]	Phase 2/Phase 3	14 participants (Actual)	Interventional	2008-10-31	Terminated (stopped due to Study halted prematurely due to some difficulties in recruitment of patients)
Treatment of Port-wine Mark in Sturge-Weber Syndrome Using Topical Timolol[NCT01533376]	Phase 1	3 participants (Actual)	Interventional	2012-02-29	Terminated
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trial Outcomes

Interim Analysis : Complete/Nearly Complete Resolution of the Target Infantile Hemangioma at Week 24 Compared to Baseline Based on the Intra-patient Blinded Centralized Independent Qualitative Assessments of Week 24 Photographs.

(NCT01056341)
Timeframe: 6 months

Intervention	percentage of participants (Number)
Placebo	8.0
Propranolol 1mg/kg/d 3 Months	9.8
Propranolol 1 mg/kg/d 6 Months	37.5
Propranolol 3 mg/kg/d 3 Months	7.7
Propranolol 3 mg/kg/d 6 Months	62.8

Primary Analysis : Complete/Nearly Complete Resolution of the Target Infantile Hemangioma at W24 Compared to Baseline Based on the Intra-patient Blinded Centralized Independent Qualitative Assessments of W24 Photographs.

(NCT01056341)
Timeframe: 6 months

Intervention	percentage of participants (Number)
Placebo	3.6
Propranolol 3mg/kg/d 6 Months	60.4

Allergy/Immunology Adverse Events

Number of allergy/immunology AE per study arm (NCT00967226)
Timeframe: enrollment through study closeout or study withdrawal up to 9 months

Intervention	Adverse Events (Number)
Allergy/Immunology Events Propranolol	1
Allergy/Immunology Events Prednisolone	1

Constitutional Adverse Events

Number of constitutional AEs in each study arm. (NCT00967226)
Timeframe: enrollment to study close out or withdrawal up to 9 months

Intervention	Adverse Events (Number)
Constitutional AEs Propranolol	2
Constitutional AEs Prednisolone	3

Decrease in Size of Hemangioma (Length x Width) in Square mm

A priori primary outcome was proportional change in the total surface area as measured by lesion's outer margin length x width at baseline minus the same measure at 4 months with surrogate data used at 5 months if 4 months not available. (NCT00967226)
Timeframe: 4-5 months after initiating therapy

Intervention	mm squared (Mean)
Propranolol	0.57
Prednisolone	0.63

Dermatologic Adverse Events

Number of Dermatologic Adverse Events in each study arm. (NCT00967226)
Timeframe: enrollment to study close out or withdrawal up to 9 months

Intervention	Adverse Events (Number)
Dermatologic AEs Propranolol	2
Dermatologic AEs Prednisolone	1

Endocrinologic Adverse Events

Number of Endocrinologic AEs (of which adrenal crisis does not overlap). (NCT00967226)
Timeframe: enrollment to close out or study withdrawal up to 9 months

Intervention	Adverse Events (Number)
Endocrine AEs Propranolol	0
Endocrinologic AEs Prednisolone	7

Gastrointestinal Adverse Events

Number of Gastrointestinal AEs in each arm (NCT00967226)
Timeframe: enrollment to study withdrawal or study close out up to 9 months

Intervention	Adverse Events (Number)
Gastrointestinal AEs Propranolol	6
Gastrointestinal AEs Prednisolone	6

Growth and Development Adverse Events

Number of Growth and Development AEs in each study arm (NCT00967226)
Timeframe: enrollment to study withdrawal or close out up to 9 months

Intervention	Adverse Events (Number)
Growth/Developoment AEs Propranolol	0
Growth/Development AEs Prednisolone	1

Infectious Adverse Events

Number of infectious AEs in each study arm (i.e. conjunctivitis, thrush, fever) (NCT00967226)
Timeframe: enrollment to study withdrawal or close out up to 9 months

Intervention	Adverse Events (Number)
Infectious AEs Propranolol	5
Infectious AEs Prednisolone	3

Metabolic or Laboratory AEs

Number of Metabolic or Laboratory AEs in each study arm. (NCT00967226)
Timeframe: enrollment to study withdrawal or close out up to 9 months

Intervention	Adverse Events (Number)
Metabolic/Laboratory AEs Propranolol	1
Metabolic/Laboratory AEs Prednisolone	0

Number of Serious Adverse Events (SAEs)

Number of serious adverse events experienced by the participants in each treatment arm within the categories adrenal crisis, growth/development, constitutional. Serious adverse events are defined as events that result in death, require either inpatient hospitalization or the prolongation of hospitalization, are life-threatening, result in a persistent or significant disability/incapacity, or result in a congenital anomaly/birth defect. Other important medical events, based upon appropriate medical judgment, may also be considered Serious Adverse Events if a trial participant's health is at risk and intervention is required to prevent an outcome mentioned. (NCT00967226)
Timeframe: enrollment until study close out or withdrawal up to 9 months

Intervention	Serious Adverse Events (Number)
Number of Serious Adverse Events in Propranolol	1
Number of Serious Adverse Events in Prednisolone	11

Pulmonary/Respiratory Adverse Events

Number of pulmonary/respiratory adverse events (CTCAE 22) in each study arm (NCT00967226)
Timeframe: enrollment through study close out or withdrawal, up to 9 months

Intervention	Adverse Events (Number)
Pulmonary/Respiratory AEs Propranolol	14
Pulmonary/Respiratory AEs Prednisolone	4

Vascular Adverse Events

Number of Vascular AEs in each study arm. (NCT00967226)
Timeframe: enrollment to study withdrawal or close out up to 9 months

Intervention	Adverse Events (Number)
Vascular AEs Propranolol	3
Vascular AEs Prednisolone	4

Tolerability of Medication

All adverse events relating to medication tolerability including: adrenal crisis, growth/development, constitutional (dehydration), allergy/immunology, dermatologic, endocrine, GI, infection, metabolism/labs, pulmonary, vascular. (NCT00967226)
Timeframe: enrollment until study close out or withdrawal up to 9 months

Intervention	Events (Number)
	Adverse Events	Serious Adverse Events
Overall Number of Adverse Events in Prednisolone	30	11
Overall Number of Adverse Events in Propranolol	34	1

Change in Lesion Volume of the Test Medication as Evaluated by MRI Examination.

Participants will be followed for the duration of the study, an expected average of 20 weeks. (NCT02335242)
Timeframe: Baseline, week 20

Intervention	percentage of volume (Mean)
Double-Blind Placebo	5.89
Open-Label Sildenafil	-8.54
Double-blind Sildenafil	-0.642

Change in Subject's Assessment of Change in Lymphatic Malformation Overall Score

"Subject's evaluation of the overall change in lymphatic malformation. Participants will be followed from baseline to 20 weeks.~Patients rated change as no improvement, minimal improvement (1-25% change), fair improvement (25-50% change), good improvement (50-75% change), and excellent improvement (75-100% change)." (NCT02335242)
Timeframe: Baseline, week 20

Intervention	Participants (Count of Participants)
	No improvement	Minimal improvement	Fair improvement	Good improvement	Excellent improvement
Double-Blind Placebo	1	2	0	2	0
Double-Blind Sildenafil	2	4	1	1	0

Reviews

2 reviews available for prednisolone and Cancer of Nose

Article	Year
[Isolated plasmablastic lymphoma of nasal mucosa in an immunocompetent patient achieving complete remission after multimodal treatment: about an African patient and literature review]. The Pan African medical journal, 2020, Volume: 37 Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy; Cyclophosphamide; Doxorubicin; Etoposide; Hu	2020
L-asparaginase-Based induction therapy for advanced extranodal NK/T-cell lymphoma. International journal of hematology, 2003, Volume: 78, Issue:3 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Disease-Free Survival; Drug Hype	2003

Trials

2 trials available for prednisolone and Cancer of Nose

Article	Year
A phase II study of ifosfamide, methotrexate, etoposide, and prednisolone for previously untreated stage I/II extranodal natural killer/T-cell lymphoma, nasal type: a multicenter trial of the Korean Cancer Study Group. The oncologist, 2014, Volume: 19, Issue:11 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Disease-Free Survival; Etoposide; Femal	2014
Treatment outcome of radiotherapy alone versus radiochemotherapy in early stage nasal natural killer/T-cell lymphoma. Medical oncology (Northwood, London, England), 2010, Volume: 27, Issue:3 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemotherapy, Ad	2010

Other Studies

21 other studies available for prednisolone and Cancer of Nose

Article	Year
CD3 International journal of hematology, 2018, Volume: 108, Issue:3 Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; CD3 Complex; CD56 Antigen; Cyclop	2018
Immunoglobulin G4-related disease of the paranasal sinuses. BMJ case reports, 2018, May-07, Volume: 2018 Topics: Aged; Autoimmune Diseases; Endoscopy; Exophthalmos; Female; Fibrosis; Glucocorticoids; Granuloma, Pl	2018
[Nasal NK/T-cell lymphoma: about two rare cases]. The Pan African medical journal, 2018, Volume: 30 Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy; Combined Modality Therapy; Cyclophosphamide;	2018
Widespread primary cutaneous diffuse large B-cell lymphoma, leg type, with nasal involvement. International wound journal, 2019, Volume: 16, Issue:4 Topics: Aged, 80 and over; Antineoplastic Agents; Humans; Leg Ulcer; Lymphoma, Large B-Cell, Diffuse; Male;	2019
Comparative Study of L-Asparaginase-Based LOP Regimen Over CHOP Regimen Before Radiotherapy for Stage IIE Extranodal Nasal Type NK/T Cell Lymphoma: A Study of 2 Centers. Clinical lymphoma, myeloma & leukemia, 2017, Volume: 17, Issue:3 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Asparagi	2017
Propranolol for severe hemangiomas of infancy. The New England journal of medicine, 2008, Jun-12, Volume: 358, Issue:24 Topics: Adrenergic beta-Antagonists; Drug Therapy, Combination; Facial Neoplasms; Glucocorticoids; Hemangiom	2008
Propranolol for severe hemangiomas of infancy. The New England journal of medicine, 2008, Jun-12, Volume: 358, Issue:24 Topics: Adrenergic beta-Antagonists; Drug Therapy, Combination; Facial Neoplasms; Glucocorticoids; Hemangiom	2008
Propranolol for severe hemangiomas of infancy. The New England journal of medicine, 2008, Jun-12, Volume: 358, Issue:24 Topics: Adrenergic beta-Antagonists; Drug Therapy, Combination; Facial Neoplasms; Glucocorticoids; Hemangiom	2008
Propranolol for severe hemangiomas of infancy. The New England journal of medicine, 2008, Jun-12, Volume: 358, Issue:24 Topics: Adrenergic beta-Antagonists; Drug Therapy, Combination; Facial Neoplasms; Glucocorticoids; Hemangiom	2008
Propranolol for severe hemangiomas of infancy. The New England journal of medicine, 2008, Jun-12, Volume: 358, Issue:24 Topics: Adrenergic beta-Antagonists; Drug Therapy, Combination; Facial Neoplasms; Glucocorticoids; Hemangiom	2008
Propranolol for severe hemangiomas of infancy. The New England journal of medicine, 2008, Jun-12, Volume: 358, Issue:24 Topics: Adrenergic beta-Antagonists; Drug Therapy, Combination; Facial Neoplasms; Glucocorticoids; Hemangiom	2008
Propranolol for severe hemangiomas of infancy. The New England journal of medicine, 2008, Jun-12, Volume: 358, Issue:24 Topics: Adrenergic beta-Antagonists; Drug Therapy, Combination; Facial Neoplasms; Glucocorticoids; Hemangiom	2008
Propranolol for severe hemangiomas of infancy. The New England journal of medicine, 2008, Jun-12, Volume: 358, Issue:24 Topics: Adrenergic beta-Antagonists; Drug Therapy, Combination; Facial Neoplasms; Glucocorticoids; Hemangiom	2008
Propranolol for severe hemangiomas of infancy. The New England journal of medicine, 2008, Jun-12, Volume: 358, Issue:24 Topics: Adrenergic beta-Antagonists; Drug Therapy, Combination; Facial Neoplasms; Glucocorticoids; Hemangiom	2008
Propranolol for severe hemangiomas of infancy. The New England journal of medicine, 2008, Jun-12, Volume: 358, Issue:24 Topics: Adrenergic beta-Antagonists; Drug Therapy, Combination; Facial Neoplasms; Glucocorticoids; Hemangiom	2008
Propranolol for severe hemangiomas of infancy. The New England journal of medicine, 2008, Jun-12, Volume: 358, Issue:24 Topics: Adrenergic beta-Antagonists; Drug Therapy, Combination; Facial Neoplasms; Glucocorticoids; Hemangiom	2008
Propranolol for severe hemangiomas of infancy. The New England journal of medicine, 2008, Jun-12, Volume: 358, Issue:24 Topics: Adrenergic beta-Antagonists; Drug Therapy, Combination; Facial Neoplasms; Glucocorticoids; Hemangiom	2008
Propranolol for severe hemangiomas of infancy. The New England journal of medicine, 2008, Jun-12, Volume: 358, Issue:24 Topics: Adrenergic beta-Antagonists; Drug Therapy, Combination; Facial Neoplasms; Glucocorticoids; Hemangiom	2008
Propranolol for severe hemangiomas of infancy. The New England journal of medicine, 2008, Jun-12, Volume: 358, Issue:24 Topics: Adrenergic beta-Antagonists; Drug Therapy, Combination; Facial Neoplasms; Glucocorticoids; Hemangiom	2008
Propranolol for severe hemangiomas of infancy. The New England journal of medicine, 2008, Jun-12, Volume: 358, Issue:24 Topics: Adrenergic beta-Antagonists; Drug Therapy, Combination; Facial Neoplasms; Glucocorticoids; Hemangiom	2008
Propranolol for severe hemangiomas of infancy. The New England journal of medicine, 2008, Jun-12, Volume: 358, Issue:24 Topics: Adrenergic beta-Antagonists; Drug Therapy, Combination; Facial Neoplasms; Glucocorticoids; Hemangiom	2008
Propranolol for severe hemangiomas of infancy. The New England journal of medicine, 2008, Jun-12, Volume: 358, Issue:24 Topics: Adrenergic beta-Antagonists; Drug Therapy, Combination; Facial Neoplasms; Glucocorticoids; Hemangiom	2008
Propranolol for severe hemangiomas of infancy. The New England journal of medicine, 2008, Jun-12, Volume: 358, Issue:24 Topics: Adrenergic beta-Antagonists; Drug Therapy, Combination; Facial Neoplasms; Glucocorticoids; Hemangiom	2008
Propranolol for severe hemangiomas of infancy. The New England journal of medicine, 2008, Jun-12, Volume: 358, Issue:24 Topics: Adrenergic beta-Antagonists; Drug Therapy, Combination; Facial Neoplasms; Glucocorticoids; Hemangiom	2008
Propranolol for severe hemangiomas of infancy. The New England journal of medicine, 2008, Jun-12, Volume: 358, Issue:24 Topics: Adrenergic beta-Antagonists; Drug Therapy, Combination; Facial Neoplasms; Glucocorticoids; Hemangiom	2008
Propranolol for severe hemangiomas of infancy. The New England journal of medicine, 2008, Jun-12, Volume: 358, Issue:24 Topics: Adrenergic beta-Antagonists; Drug Therapy, Combination; Facial Neoplasms; Glucocorticoids; Hemangiom	2008
Propranolol for severe hemangiomas of infancy. The New England journal of medicine, 2008, Jun-12, Volume: 358, Issue:24 Topics: Adrenergic beta-Antagonists; Drug Therapy, Combination; Facial Neoplasms; Glucocorticoids; Hemangiom	2008
Propranolol for severe hemangiomas of infancy. The New England journal of medicine, 2008, Jun-12, Volume: 358, Issue:24 Topics: Adrenergic beta-Antagonists; Drug Therapy, Combination; Facial Neoplasms; Glucocorticoids; Hemangiom	2008
Propranolol for severe hemangiomas of infancy. The New England journal of medicine, 2008, Jun-12, Volume: 358, Issue:24 Topics: Adrenergic beta-Antagonists; Drug Therapy, Combination; Facial Neoplasms; Glucocorticoids; Hemangiom	2008
Propranolol for severe hemangiomas of infancy. The New England journal of medicine, 2008, Jun-12, Volume: 358, Issue:24 Topics: Adrenergic beta-Antagonists; Drug Therapy, Combination; Facial Neoplasms; Glucocorticoids; Hemangiom	2008
Propranolol for severe hemangiomas of infancy. The New England journal of medicine, 2008, Jun-12, Volume: 358, Issue:24 Topics: Adrenergic beta-Antagonists; Drug Therapy, Combination; Facial Neoplasms; Glucocorticoids; Hemangiom	2008
Propranolol for severe hemangiomas of infancy. The New England journal of medicine, 2008, Jun-12, Volume: 358, Issue:24 Topics: Adrenergic beta-Antagonists; Drug Therapy, Combination; Facial Neoplasms; Glucocorticoids; Hemangiom	2008
Propranolol for severe hemangiomas of infancy. The New England journal of medicine, 2008, Jun-12, Volume: 358, Issue:24 Topics: Adrenergic beta-Antagonists; Drug Therapy, Combination; Facial Neoplasms; Glucocorticoids; Hemangiom	2008
Propranolol for severe hemangiomas of infancy. The New England journal of medicine, 2008, Jun-12, Volume: 358, Issue:24 Topics: Adrenergic beta-Antagonists; Drug Therapy, Combination; Facial Neoplasms; Glucocorticoids; Hemangiom	2008
Propranolol for severe hemangiomas of infancy. The New England journal of medicine, 2008, Jun-12, Volume: 358, Issue:24 Topics: Adrenergic beta-Antagonists; Drug Therapy, Combination; Facial Neoplasms; Glucocorticoids; Hemangiom	2008
Propranolol for severe hemangiomas of infancy. The New England journal of medicine, 2008, Jun-12, Volume: 358, Issue:24 Topics: Adrenergic beta-Antagonists; Drug Therapy, Combination; Facial Neoplasms; Glucocorticoids; Hemangiom	2008
Propranolol for severe hemangiomas of infancy. The New England journal of medicine, 2008, Jun-12, Volume: 358, Issue:24 Topics: Adrenergic beta-Antagonists; Drug Therapy, Combination; Facial Neoplasms; Glucocorticoids; Hemangiom	2008
Propranolol for severe hemangiomas of infancy. The New England journal of medicine, 2008, Jun-12, Volume: 358, Issue:24 Topics: Adrenergic beta-Antagonists; Drug Therapy, Combination; Facial Neoplasms; Glucocorticoids; Hemangiom	2008
Propranolol for severe hemangiomas of infancy. The New England journal of medicine, 2008, Jun-12, Volume: 358, Issue:24 Topics: Adrenergic beta-Antagonists; Drug Therapy, Combination; Facial Neoplasms; Glucocorticoids; Hemangiom	2008
Propranolol for severe hemangiomas of infancy. The New England journal of medicine, 2008, Jun-12, Volume: 358, Issue:24 Topics: Adrenergic beta-Antagonists; Drug Therapy, Combination; Facial Neoplasms; Glucocorticoids; Hemangiom	2008
Propranolol for severe hemangiomas of infancy. The New England journal of medicine, 2008, Jun-12, Volume: 358, Issue:24 Topics: Adrenergic beta-Antagonists; Drug Therapy, Combination; Facial Neoplasms; Glucocorticoids; Hemangiom	2008
Propranolol for severe hemangiomas of infancy. The New England journal of medicine, 2008, Jun-12, Volume: 358, Issue:24 Topics: Adrenergic beta-Antagonists; Drug Therapy, Combination; Facial Neoplasms; Glucocorticoids; Hemangiom	2008
Propranolol for severe hemangiomas of infancy. The New England journal of medicine, 2008, Jun-12, Volume: 358, Issue:24 Topics: Adrenergic beta-Antagonists; Drug Therapy, Combination; Facial Neoplasms; Glucocorticoids; Hemangiom	2008
Propranolol for severe hemangiomas of infancy. The New England journal of medicine, 2008, Jun-12, Volume: 358, Issue:24 Topics: Adrenergic beta-Antagonists; Drug Therapy, Combination; Facial Neoplasms; Glucocorticoids; Hemangiom	2008
Propranolol for severe hemangiomas of infancy. The New England journal of medicine, 2008, Jun-12, Volume: 358, Issue:24 Topics: Adrenergic beta-Antagonists; Drug Therapy, Combination; Facial Neoplasms; Glucocorticoids; Hemangiom	2008
Propranolol for severe hemangiomas of infancy. The New England journal of medicine, 2008, Jun-12, Volume: 358, Issue:24 Topics: Adrenergic beta-Antagonists; Drug Therapy, Combination; Facial Neoplasms; Glucocorticoids; Hemangiom	2008
Propranolol for severe hemangiomas of infancy. The New England journal of medicine, 2008, Jun-12, Volume: 358, Issue:24 Topics: Adrenergic beta-Antagonists; Drug Therapy, Combination; Facial Neoplasms; Glucocorticoids; Hemangiom	2008
Propranolol for severe hemangiomas of infancy. The New England journal of medicine, 2008, Jun-12, Volume: 358, Issue:24 Topics: Adrenergic beta-Antagonists; Drug Therapy, Combination; Facial Neoplasms; Glucocorticoids; Hemangiom	2008
Propranolol for severe hemangiomas of infancy. The New England journal of medicine, 2008, Jun-12, Volume: 358, Issue:24 Topics: Adrenergic beta-Antagonists; Drug Therapy, Combination; Facial Neoplasms; Glucocorticoids; Hemangiom	2008
Propranolol for severe hemangiomas of infancy. The New England journal of medicine, 2008, Jun-12, Volume: 358, Issue:24 Topics: Adrenergic beta-Antagonists; Drug Therapy, Combination; Facial Neoplasms; Glucocorticoids; Hemangiom	2008
Propranolol for severe hemangiomas of infancy. The New England journal of medicine, 2008, Jun-12, Volume: 358, Issue:24 Topics: Adrenergic beta-Antagonists; Drug Therapy, Combination; Facial Neoplasms; Glucocorticoids; Hemangiom	2008
Propranolol for severe hemangiomas of infancy. The New England journal of medicine, 2008, Jun-12, Volume: 358, Issue:24 Topics: Adrenergic beta-Antagonists; Drug Therapy, Combination; Facial Neoplasms; Glucocorticoids; Hemangiom	2008
Propranolol for severe hemangiomas of infancy. The New England journal of medicine, 2008, Jun-12, Volume: 358, Issue:24 Topics: Adrenergic beta-Antagonists; Drug Therapy, Combination; Facial Neoplasms; Glucocorticoids; Hemangiom	2008
Propranolol for severe hemangiomas of infancy. The New England journal of medicine, 2008, Jun-12, Volume: 358, Issue:24 Topics: Adrenergic beta-Antagonists; Drug Therapy, Combination; Facial Neoplasms; Glucocorticoids; Hemangiom	2008
Propranolol for severe hemangiomas of infancy. The New England journal of medicine, 2008, Jun-12, Volume: 358, Issue:24 Topics: Adrenergic beta-Antagonists; Drug Therapy, Combination; Facial Neoplasms; Glucocorticoids; Hemangiom	2008
Propranolol for severe hemangiomas of infancy. The New England journal of medicine, 2008, Jun-12, Volume: 358, Issue:24 Topics: Adrenergic beta-Antagonists; Drug Therapy, Combination; Facial Neoplasms; Glucocorticoids; Hemangiom	2008
Propranolol for severe hemangiomas of infancy. The New England journal of medicine, 2008, Jun-12, Volume: 358, Issue:24 Topics: Adrenergic beta-Antagonists; Drug Therapy, Combination; Facial Neoplasms; Glucocorticoids; Hemangiom	2008
Propranolol for severe hemangiomas of infancy. The New England journal of medicine, 2008, Jun-12, Volume: 358, Issue:24 Topics: Adrenergic beta-Antagonists; Drug Therapy, Combination; Facial Neoplasms; Glucocorticoids; Hemangiom	2008
Propranolol for severe hemangiomas of infancy. The New England journal of medicine, 2008, Jun-12, Volume: 358, Issue:24 Topics: Adrenergic beta-Antagonists; Drug Therapy, Combination; Facial Neoplasms; Glucocorticoids; Hemangiom	2008
Propranolol for severe hemangiomas of infancy. The New England journal of medicine, 2008, Jun-12, Volume: 358, Issue:24 Topics: Adrenergic beta-Antagonists; Drug Therapy, Combination; Facial Neoplasms; Glucocorticoids; Hemangiom	2008
Propranolol for severe hemangiomas of infancy. The New England journal of medicine, 2008, Jun-12, Volume: 358, Issue:24 Topics: Adrenergic beta-Antagonists; Drug Therapy, Combination; Facial Neoplasms; Glucocorticoids; Hemangiom	2008
Propranolol for severe hemangiomas of infancy. The New England journal of medicine, 2008, Jun-12, Volume: 358, Issue:24 Topics: Adrenergic beta-Antagonists; Drug Therapy, Combination; Facial Neoplasms; Glucocorticoids; Hemangiom	2008
Propranolol for severe hemangiomas of infancy. The New England journal of medicine, 2008, Jun-12, Volume: 358, Issue:24 Topics: Adrenergic beta-Antagonists; Drug Therapy, Combination; Facial Neoplasms; Glucocorticoids; Hemangiom	2008
Propranolol for severe hemangiomas of infancy. The New England journal of medicine, 2008, Jun-12, Volume: 358, Issue:24 Topics: Adrenergic beta-Antagonists; Drug Therapy, Combination; Facial Neoplasms; Glucocorticoids; Hemangiom	2008
Propranolol for severe hemangiomas of infancy. The New England journal of medicine, 2008, Jun-12, Volume: 358, Issue:24 Topics: Adrenergic beta-Antagonists; Drug Therapy, Combination; Facial Neoplasms; Glucocorticoids; Hemangiom	2008
Propranolol for severe hemangiomas of infancy. The New England journal of medicine, 2008, Jun-12, Volume: 358, Issue:24 Topics: Adrenergic beta-Antagonists; Drug Therapy, Combination; Facial Neoplasms; Glucocorticoids; Hemangiom	2008
Propranolol for severe hemangiomas of infancy. The New England journal of medicine, 2008, Jun-12, Volume: 358, Issue:24 Topics: Adrenergic beta-Antagonists; Drug Therapy, Combination; Facial Neoplasms; Glucocorticoids; Hemangiom	2008
Propranolol for severe hemangiomas of infancy. The New England journal of medicine, 2008, Jun-12, Volume: 358, Issue:24 Topics: Adrenergic beta-Antagonists; Drug Therapy, Combination; Facial Neoplasms; Glucocorticoids; Hemangiom	2008
Propranolol for severe hemangiomas of infancy. The New England journal of medicine, 2008, Jun-12, Volume: 358, Issue:24 Topics: Adrenergic beta-Antagonists; Drug Therapy, Combination; Facial Neoplasms; Glucocorticoids; Hemangiom	2008
Propranolol for severe hemangiomas of infancy. The New England journal of medicine, 2008, Jun-12, Volume: 358, Issue:24 Topics: Adrenergic beta-Antagonists; Drug Therapy, Combination; Facial Neoplasms; Glucocorticoids; Hemangiom	2008
Propranolol for severe hemangiomas of infancy. The New England journal of medicine, 2008, Jun-12, Volume: 358, Issue:24 Topics: Adrenergic beta-Antagonists; Drug Therapy, Combination; Facial Neoplasms; Glucocorticoids; Hemangiom	2008
Propranolol for severe hemangiomas of infancy. The New England journal of medicine, 2008, Jun-12, Volume: 358, Issue:24 Topics: Adrenergic beta-Antagonists; Drug Therapy, Combination; Facial Neoplasms; Glucocorticoids; Hemangiom	2008
Propranolol for severe hemangiomas of infancy. The New England journal of medicine, 2008, Jun-12, Volume: 358, Issue:24 Topics: Adrenergic beta-Antagonists; Drug Therapy, Combination; Facial Neoplasms; Glucocorticoids; Hemangiom	2008
Propranolol for severe hemangiomas of infancy. The New England journal of medicine, 2008, Jun-12, Volume: 358, Issue:24 Topics: Adrenergic beta-Antagonists; Drug Therapy, Combination; Facial Neoplasms; Glucocorticoids; Hemangiom	2008
Propranolol for severe hemangiomas of infancy. The New England journal of medicine, 2008, Jun-12, Volume: 358, Issue:24 Topics: Adrenergic beta-Antagonists; Drug Therapy, Combination; Facial Neoplasms; Glucocorticoids; Hemangiom	2008
Propranolol for severe hemangiomas of infancy. The New England journal of medicine, 2008, Jun-12, Volume: 358, Issue:24 Topics: Adrenergic beta-Antagonists; Drug Therapy, Combination; Facial Neoplasms; Glucocorticoids; Hemangiom	2008
Propranolol for severe hemangiomas of infancy. The New England journal of medicine, 2008, Jun-12, Volume: 358, Issue:24 Topics: Adrenergic beta-Antagonists; Drug Therapy, Combination; Facial Neoplasms; Glucocorticoids; Hemangiom	2008
Propranolol for severe hemangiomas of infancy. The New England journal of medicine, 2008, Jun-12, Volume: 358, Issue:24 Topics: Adrenergic beta-Antagonists; Drug Therapy, Combination; Facial Neoplasms; Glucocorticoids; Hemangiom	2008
Propranolol for severe hemangiomas of infancy. The New England journal of medicine, 2008, Jun-12, Volume: 358, Issue:24 Topics: Adrenergic beta-Antagonists; Drug Therapy, Combination; Facial Neoplasms; Glucocorticoids; Hemangiom	2008
Propranolol for severe hemangiomas of infancy. The New England journal of medicine, 2008, Jun-12, Volume: 358, Issue:24 Topics: Adrenergic beta-Antagonists; Drug Therapy, Combination; Facial Neoplasms; Glucocorticoids; Hemangiom	2008
Propranolol for severe hemangiomas of infancy. The New England journal of medicine, 2008, Jun-12, Volume: 358, Issue:24 Topics: Adrenergic beta-Antagonists; Drug Therapy, Combination; Facial Neoplasms; Glucocorticoids; Hemangiom	2008
Propranolol for severe hemangiomas of infancy. The New England journal of medicine, 2008, Jun-12, Volume: 358, Issue:24 Topics: Adrenergic beta-Antagonists; Drug Therapy, Combination; Facial Neoplasms; Glucocorticoids; Hemangiom	2008
Propranolol for severe hemangiomas of infancy. The New England journal of medicine, 2008, Jun-12, Volume: 358, Issue:24 Topics: Adrenergic beta-Antagonists; Drug Therapy, Combination; Facial Neoplasms; Glucocorticoids; Hemangiom	2008
Propranolol for severe hemangiomas of infancy. The New England journal of medicine, 2008, Jun-12, Volume: 358, Issue:24 Topics: Adrenergic beta-Antagonists; Drug Therapy, Combination; Facial Neoplasms; Glucocorticoids; Hemangiom	2008
Propranolol for severe hemangiomas of infancy. The New England journal of medicine, 2008, Jun-12, Volume: 358, Issue:24 Topics: Adrenergic beta-Antagonists; Drug Therapy, Combination; Facial Neoplasms; Glucocorticoids; Hemangiom	2008
Propranolol for severe hemangiomas of infancy. The New England journal of medicine, 2008, Jun-12, Volume: 358, Issue:24 Topics: Adrenergic beta-Antagonists; Drug Therapy, Combination; Facial Neoplasms; Glucocorticoids; Hemangiom	2008
Propranolol for severe hemangiomas of infancy. The New England journal of medicine, 2008, Jun-12, Volume: 358, Issue:24 Topics: Adrenergic beta-Antagonists; Drug Therapy, Combination; Facial Neoplasms; Glucocorticoids; Hemangiom	2008
Propranolol for severe hemangiomas of infancy. The New England journal of medicine, 2008, Jun-12, Volume: 358, Issue:24 Topics: Adrenergic beta-Antagonists; Drug Therapy, Combination; Facial Neoplasms; Glucocorticoids; Hemangiom	2008
Propranolol for severe hemangiomas of infancy. The New England journal of medicine, 2008, Jun-12, Volume: 358, Issue:24 Topics: Adrenergic beta-Antagonists; Drug Therapy, Combination; Facial Neoplasms; Glucocorticoids; Hemangiom	2008
Propranolol for severe hemangiomas of infancy. The New England journal of medicine, 2008, Jun-12, Volume: 358, Issue:24 Topics: Adrenergic beta-Antagonists; Drug Therapy, Combination; Facial Neoplasms; Glucocorticoids; Hemangiom	2008
Propranolol for severe hemangiomas of infancy. The New England journal of medicine, 2008, Jun-12, Volume: 358, Issue:24 Topics: Adrenergic beta-Antagonists; Drug Therapy, Combination; Facial Neoplasms; Glucocorticoids; Hemangiom	2008
Propranolol for severe hemangiomas of infancy. The New England journal of medicine, 2008, Jun-12, Volume: 358, Issue:24 Topics: Adrenergic beta-Antagonists; Drug Therapy, Combination; Facial Neoplasms; Glucocorticoids; Hemangiom	2008
Propranolol for severe hemangiomas of infancy. The New England journal of medicine, 2008, Jun-12, Volume: 358, Issue:24 Topics: Adrenergic beta-Antagonists; Drug Therapy, Combination; Facial Neoplasms; Glucocorticoids; Hemangiom	2008
Propranolol for severe hemangiomas of infancy. The New England journal of medicine, 2008, Jun-12, Volume: 358, Issue:24 Topics: Adrenergic beta-Antagonists; Drug Therapy, Combination; Facial Neoplasms; Glucocorticoids; Hemangiom	2008
Propranolol for severe hemangiomas of infancy. The New England journal of medicine, 2008, Jun-12, Volume: 358, Issue:24 Topics: Adrenergic beta-Antagonists; Drug Therapy, Combination; Facial Neoplasms; Glucocorticoids; Hemangiom	2008
Propranolol for severe hemangiomas of infancy. The New England journal of medicine, 2008, Jun-12, Volume: 358, Issue:24 Topics: Adrenergic beta-Antagonists; Drug Therapy, Combination; Facial Neoplasms; Glucocorticoids; Hemangiom	2008
Propranolol for severe hemangiomas of infancy. The New England journal of medicine, 2008, Jun-12, Volume: 358, Issue:24 Topics: Adrenergic beta-Antagonists; Drug Therapy, Combination; Facial Neoplasms; Glucocorticoids; Hemangiom	2008
Propranolol for severe hemangiomas of infancy. The New England journal of medicine, 2008, Jun-12, Volume: 358, Issue:24 Topics: Adrenergic beta-Antagonists; Drug Therapy, Combination; Facial Neoplasms; Glucocorticoids; Hemangiom	2008
Propranolol for severe hemangiomas of infancy. The New England journal of medicine, 2008, Jun-12, Volume: 358, Issue:24 Topics: Adrenergic beta-Antagonists; Drug Therapy, Combination; Facial Neoplasms; Glucocorticoids; Hemangiom	2008
Propranolol for severe hemangiomas of infancy. The New England journal of medicine, 2008, Jun-12, Volume: 358, Issue:24 Topics: Adrenergic beta-Antagonists; Drug Therapy, Combination; Facial Neoplasms; Glucocorticoids; Hemangiom	2008
Propranolol for severe hemangiomas of infancy. The New England journal of medicine, 2008, Jun-12, Volume: 358, Issue:24 Topics: Adrenergic beta-Antagonists; Drug Therapy, Combination; Facial Neoplasms; Glucocorticoids; Hemangiom	2008
Propranolol for severe hemangiomas of infancy. The New England journal of medicine, 2008, Jun-12, Volume: 358, Issue:24 Topics: Adrenergic beta-Antagonists; Drug Therapy, Combination; Facial Neoplasms; Glucocorticoids; Hemangiom	2008
Propranolol for severe hemangiomas of infancy. The New England journal of medicine, 2008, Jun-12, Volume: 358, Issue:24 Topics: Adrenergic beta-Antagonists; Drug Therapy, Combination; Facial Neoplasms; Glucocorticoids; Hemangiom	2008
Propranolol for severe hemangiomas of infancy. The New England journal of medicine, 2008, Jun-12, Volume: 358, Issue:24 Topics: Adrenergic beta-Antagonists; Drug Therapy, Combination; Facial Neoplasms; Glucocorticoids; Hemangiom	2008
Propranolol for severe hemangiomas of infancy. The New England journal of medicine, 2008, Jun-12, Volume: 358, Issue:24 Topics: Adrenergic beta-Antagonists; Drug Therapy, Combination; Facial Neoplasms; Glucocorticoids; Hemangiom	2008
NF-kappaB activation through the alternative pathway correlates with chemoresistance and poor survival in extranodal NK/T-cell lymphoma, nasal type. Japanese journal of clinical oncology, 2009, Volume: 39, Issue:7 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cell Nucleus; Cyclophospham	2009
Facial basal cell carcinoma in a young patient with Crohn disease. The Journal of craniofacial surgery, 2010, Volume: 21, Issue:6 Topics: Adult; Anti-Inflammatory Agents; Azathioprine; Carcinoma, Basal Cell; Crohn Disease; Facial Neoplasm	2010
THE MANAGEMENT OF MALIGNANT GRANULOMA. Proceedings of the Royal Society of Medicine, 1964, Volume: 57 Topics: Diagnosis; Diagnosis, Differential; Granuloma; Granulomatosis with Polyangiitis; Hodgkin Disease; Hu	1964
Successful treatment of disseminated nasal T-cell lymphoma using high-dose chemotherapy and autologus peripheral blood stem cell transplantation: a case report. Auris, nasus, larynx, 2004, Volume: 31, Issue:1 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Cycloph	2004
Midline NK/T-cell lymphoma nasal-type: treatment outcome, the effect of L-asparaginase based regimen, and prognostic factors. Hematological oncology, 2006, Volume: 24, Issue:1 Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Aspa	2006
[Case series of localized nasal NK/T-cell lymphoma treated with preceding intensified local radiation therapy before systemic chemotherapy]. Gan to kagaku ryoho. Cancer & chemotherapy, 2006, Volume: 33, Issue:5 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy;	2006
Mediastinal single nodal relapse of a nasal NK/T cell lymphoma. The Korean journal of internal medicine, 2007, Volume: 22, Issue:3 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide;	2007
Primary transmissible venereal tumour in the nasal cavity of a dog. The Veterinary record, 1995, Mar-04, Volume: 136, Issue:9 Topics: Animals; Anti-Bacterial Agents; Dog Diseases; Dogs; Drug Therapy, Combination; Male; Nasal Cavity; N	1995
Mast cell tumor in the nasal cavity of a dog. The Journal of veterinary medical science, 2000, Volume: 62, Issue:9 Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide	2000
An unusual complication of the treatment of a hemangioma. Annals of plastic surgery, 2002, Volume: 48, Issue:1 Topics: Antineoplastic Agents, Hormonal; Cardiomyopathy, Hypertrophic; Hemangioma; Humans; Infant; Male; Nos	2002
[Clinical characteristics and treatment of midline nasal and nasal type NK/T cell lymphoma]. Zhonghua yi xue za zhi, 2001, Jul-10, Volume: 81, Issue:13 Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Aspa	2001
Successful treatment of nasal T-cell lymphoma with a combination of local irradiation and high-dose chemotherapy. International journal of hematology, 2002, Volume: 75, Issue:2 Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Doxorub	2002
Intranasal squamous cell carcinoma in a renal transplant recipient on long term immunosuppression. Postgraduate medical journal, 1987, Volume: 63, Issue:745 Topics: Adult; Azathioprine; Carcinoma, Squamous Cell; Female; Humans; Immunosuppressive Agents; Kidney Tran	1987
Unusual cases of myelomatosis. Scandinavian journal of haematology, 1974, Volume: 12, Issue:2 Topics: Aged; Autopsy; Biopsy; Bone Marrow Cells; Cyclophosphamide; Female; Heart Neoplasms; Humans; Kidney	1974
Chloroma of the nose. The Journal of laryngology and otology, 1969, Volume: 83, Issue:7 Topics: Child; Female; Fundus Oculi; Humans; Leukemia, Myeloid; Nose Neoplasms; Prednisolone	1969